Group One Trading, L.P. Brooklyn Immuno Therapeutics, Inc. Transaction History

Group One Trading, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	BUY	$0.23 - $0.71 $67 - $208	294 New	294 $0
Q2 2022 Aug 11, 2022	SELL	$0.48 - $2.03 $988 - $4,179	-2,059 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$1.76 - $4.84 $880 - $2,420	-500 Reduced 19.54%	2,059 $4,000
Q4 2021 Feb 11, 2022	BUY	$4.17 - $9.79 $10,671 - $25,052	2,559 New	2,559 $11,000
Q3 2021 Nov 12, 2021	SELL	$8.86 - $17.05 $142,583 - $274,385	-16,093 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$3.75 - $78.5 $60,348 - $1.26 Million	16,093 New	16,093 $290,000

1.21M

Ticker BTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,825,700
Description
Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company also develops therapies using gene-editing and cell therapy techno...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.